|
Patient-specific therapy of glioblastoma using lightly-labeled [14C]-temozolomide
|
1R43CA134184-01
|
$102,900
|
|
Arjomand, Ali
|
ACCIUM BIOSCIENCES, INC.
|
|
Add-on module for ONCAD for diagnosing infiltrating lobular carcinoma
|
1R43CA132259-01A1
|
$100,058
|
|
PENN, ALAN
|
ALAN PENN AND ASSOCIATES, INC.
|
|
Education for Healthcare Providers of Alaska Natives
|
5R25CA104120-05
|
$307,210
|
|
Lanier, Anne
|
ALASKA NATIVE TRIBAL HEALTH CONSORTIUM
|
|
Experimental Models for Testing Novel Targets for Pancreatic Cancer Cell Invasion
|
1R21CA124931-01A1
|
$167,475
|
|
MOUSA, SHAKER
|
ALBANY COLLEGE OF PHARMACY
|
|
Fibronectin Polymerization: Effects on Cell Signaling
|
5R01CA069612-12
|
$271,548
|
|
MC KEOWN-LONGO, PAULA
|
ALBANY MEDICAL COLLEGE
|
|
Computer-aided tool for diagnostic breast ultrasound
|
5R44CA112858-03
|
$443,533
|
|
Galperin, Michael
|
ALMEN LABORATORIES, INC.
|
|
Young Minority Scientists in the Field of Cancer
|
5R13CA040577-23
|
$214,489
|
|
CLARKSON, BAYARD
|
AMERICAN ASSOCIATION FOR CANCER RESEARCH
|
|
MSI Faculty in the Field of Cancer
|
5R13CA076526-12
|
$78,120
|
|
FOTI, MARGARET
|
AMERICAN ASSOCIATION FOR CANCER RESEARCH
|
|
Characterizing Genetic Susceptibility to Breast and Prostate Cancer: The BPC3.
|
2U01CA098710-05
|
$1,063,219
|
|
THUN, MICHAEL
|
AMERICAN CANCER SOCIETY, INC.
|
|
QUALITY RESEARCH IN RADIATION ONCOLOGY: ACR PCS
|
5R01CA065435-10
|
$740,839
|
|
WILSON, JESSE
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Adenoviral GFP targeting of metastatic human tumors using multiple delivery route
|
1R43CA132242-01
|
$149,575
|
|
Kishimoto, Hiroyuki
|
ANTICANCER, INC.
|
|
402 - RFP: N43-CM-87007-68 TOPIC 251: DEVELOPMENT OF ANTICANCER AGENTS REQUEST
|
N43CM800026-000
|
$149,558
|
|
CASTOR, TREVOR
|
APHIOS CORP:1105999
|
|
SBIR Phase I- Topic 247- Portable e-Technology Diet and Physical Activity Tools f
|
N43CO800037-000
|
$149,955
|
|
LI, HUIPING
|
APPLIED MEDIA ANALYSIS INC:1145653
|
|
An Exploration of Perceived Racial/Ethnic Discrimination in Cancer Care Delivery
|
5R03CA124752-02
|
$77,999
|
|
Campesino, Maureen
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
PHASE I AND II CLINICAL TRIALS OF CANCER CHEMOPREVENTIVE AGENTS
|
N01CN035158-009
|
$1,500,000
|
|
CHOW, SHERRY
|
ARIZONA UNIV:1109859
|
|
Image-Guided System for Cancer Intervention
|
2R42CA115112-02A2
|
$591,060
|
|
Vosburgh, Kirby
|
ASCENSION TECHNOLOGY CORPORATION
|
|
Drug Delivery Carriers Targeted to Breast Tumor by Fusion Phage Proteins
|
5R01CA125063-02
|
$373,539
|
|
PETRENKO, VALERY
|
AUBURN UNIVERSITY AT AUBURN
|
|
Targeted Gene Therapy for Lymphoma
|
5R01CA113454-03
|
$256,177
|
|
SMITH, BRUCE
|
AUBURN UNIVERSITY AT AUBURN
|
|
SURVEILLANCE SUPPORT SERVICES FOR THE NATIONAL CANCER INSTITUTE
|
N02PC513001-003
|
$859
|
|
MANNINEN, DIANE
|
BATTELLE MEMORIAL INSTITUTE:1107037
|
|
Bay Area Tumor Institute CCOP
|
5U10CA045461-19
|
$481,201
|
|
Feusner, James
|
BAY AREA TUMOR INSTITUTE
|
|
Targeting Relaxin Signaling in Prostate Cancer
|
5R21CA118362-02
|
$150,000
|
|
Agoulnik, Alexander
|
BAYLOR COLLEGE OF MEDICINE
|
|
PROP SENSITIVITY AND OBESITY AMONG ETHNIC CHILDREN
|
5R01CA116766-04
|
$391,200
|
|
Baranowski, Tom
|
BAYLOR COLLEGE OF MEDICINE
|
|
Molecular Mechanisms by which Rexinoids Prevent Breast Cancer
|
5R01CA078480-11
|
$341,085
|
|
BROWN, POWEL
|
BAYLOR COLLEGE OF MEDICINE
|
|
SV40 Pathogenesis of Human Infections
|
5R01CA104818-05
|
$467,229
|
$233,615
|
BUTEL, JANET
|
BAYLOR COLLEGE OF MEDICINE
|
|
Breast cancer response markers to a dual HER1/2 blocker
|
5R01CA112305-04
|
$252,236
|
|
CHANG, JENNY
|
BAYLOR COLLEGE OF MEDICINE
|
|
NR4A Nuclear Receptor Function in Leukemia
|
5R01CA111411-03
|
$258,529
|
|
CONNEELY, ORLA
|
BAYLOR COLLEGE OF MEDICINE
|
|
Guideline-based surveillance and treatment of hepatocellular carcinoma
|
5R01CA160738-03
|
$244,203
|
$244,203
|
Davila, Jessica
|
BAYLOR COLLEGE OF MEDICINE
|
|
Contributions of Epstein-Barr Virus EBNA2 and EBNA-LP to B cell immortalization
|
5F31CA126523-02
|
$35,140
|
|
Echendu, Chisaroka
|
BAYLOR COLLEGE OF MEDICINE
|
|
Obesity, H pylori and Risk of Barrett's Esophagus
|
5R01CA116845-02
|
$562,889
|
|
EL-SERAG, HASHEM
|
BAYLOR COLLEGE OF MEDICINE
|
|
Proteosome Inhibition Therapy for Hematologic Malignancy
|
5K23CA113775-03
|
$134,015
|
|
HORTON, TERZAH
|
BAYLOR COLLEGE OF MEDICINE
|
|
A Novel Inhibitor of Stat3 for Prostate Cancer Therapy
|
5R01CA104035-04
|
$280,899
|
|
JING, NAIJIE
|
BAYLOR COLLEGE OF MEDICINE
|
|
Role of PML nuclear body proteins for establishment of EBV latent infection
|
5R01CA124309-03
|
$258,530
|
|
Ling, Paul
|
BAYLOR COLLEGE OF MEDICINE
|
|
Novel Gene Networks in Breast Development and Cancer
|
5P01CA030195-26
|
$2,398,875
|
|
Oesterreich, Steffi
|
BAYLOR COLLEGE OF MEDICINE
|
|
Translational Research in Breast Cancer
|
2P50CA058183-14
|
$2,300,000
|
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-02S1
|
$117,286
|
$1,173
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-07S1
|
$75,000
|
$750
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-07S2
|
$43,265
|
$433
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-02
|
$1,515,000
|
$15,150
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-07
|
$3,092,811
|
$30,928
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Pediatric Oncology Research Training Program
|
5T32CA115303-03
|
$372,589
|
|
Poplack, David
|
BAYLOR COLLEGE OF MEDICINE
|
|
Co-evolution of the Reactive Microenvironment in Prostate Cancer Progression
|
5U54CA126568-03
|
$529,800
|
|
ROWLEY, DAVID
|
BAYLOR COLLEGE OF MEDICINE
|
|
Reducing Missed And Delayed Diagnoses In Cancer: Lessons From Aviation
|
5K23CA125585-02
|
$141,750
|
|
SINGH, HARDEEP
|
BAYLOR COLLEGE OF MEDICINE
|
|
Mechanism and Consequences of Telomere Dysfunction
|
1R01CA133249-01
|
$318,513
|
|
Songyang, Zhou
|
BAYLOR COLLEGE OF MEDICINE
|
|
Study of Valproic Acid in Pediatric Brain Tumors
|
5K23CA113721-03
|
$135,036
|
|
SU, JACK
|
BAYLOR COLLEGE OF MEDICINE
|
|
Targets of Vitamin D Receptor Action in Prostate
|
5R01CA107691-05
|
$292,538
|
|
Weigel, Nancy
|
BAYLOR COLLEGE OF MEDICINE
|
|
The Role of Mitochondrial DNA Alterations in Cancer
|
5R01CA100023-05
|
$291,567
|
|
Wong, Lee-Jun
|
BAYLOR COLLEGE OF MEDICINE
|
|
Improving the Efficacy of Dendritic Cell Vaccines
|
5P01CA084512-07
|
$985,145
|
|
Banchereau, Jacques
|
BAYLOR RESEARCH INSTITUTE
|
|
The Biology and Diagnosis of Hereditary Non-Polyposis Colorectal Cancer (HNPCC)
|
5R01CA072851-13
|
$326,412
|
|
BOLAND, Clement
|
BAYLOR RESEARCH INSTITUTE
|
|
A Pull-Push Strategy for Lymphoma Immunotherapy
|
5K08CA105064-05
|
$128,547
|
|
Song, Wenru
|
BAYLOR RESEARCH INSTITUTE
|
|
Botanical-derived drug discovery for cancer therapy
|
1R43CA114876-01A2
|
$130,207
|
|
Norris, Andrew
|
BCN BIOSCIENCES, LLC
|
Total relevant funding to Organ Transplantation Research for this search: $79,804,195
|